Supporting a New Drug Launch for a Pharma Company – Infiniti’s Latest Product Launch Engagement

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest new product launch strategy for a pharma company. During this engagement, the experts at Infiniti Research helped the client to devise a sound pharmaceutical product launch strategy. Also, this article explains in detail the approach undertaken by the experts at Infiniti Research to help the client clear the pre-clinical testing for their new injectable cholesterol drug in the first attempt.

The pharma market is far more competitive than it used to be a decade ago. A multitude of new drugs are being introduced in the market daily. But, only a few among them gain traction and achieve success. This is because major businesses spend millions of dollars on product development stages and ignore the most important process such as the product launch and promotion. Leveraging product launch strategy can help businesses to develop a winning go-to-market strategy plan.

Having a sound product launch plan is pre-requisite for businesses to better position a new product in the market. We’re here to help. Request a free proposal today.

The business challenge: The client is a retail company based out of Europe. They wanted to launch their new injectable cholesterol drug launch in the market. However, they lacked an understanding of the current market condition and key value drivers to set optimal launch prices. Also, they faced challenges in adopting strategies to tackle supply chain complexities and meet manufacturing quality requirement. Therefore, they realized the need to devise a product launch strategy. To do so, they approached the experts at Infiniti Research to leverage their expertise in offering new product launch engagement.

Our experts can support you in successfully launching a new product in a new or existing market. Contact us.

The solution offered: By conducting a risk analysis engagement, our experts helped the client to identify all the risk related to supply chain operations and new drug R&D. Also, our experts conducted a price analysis study, where they helped the client to competitively price the new drug based on the market demand and competitors’ pricing strategies. In addition, our experts helped the client to identify the right marketing channels to promote their new drug in the market.

The insights obtained from our engagement helped the client to devise a winning go-to-market strategy and clear the pre-clinical testing for their new injectable cholesterol drug in the first attempt. Also, the client was able to identify the right partners to out-license their drug and generate sales of over €1.2 million in a year.

Infiniti’s new product launch engagement helped the client to:

• Adopt risk management approaches by understanding the current and potential risks in the market
• Devise a marketing and sales plan for promoting their new drug
• Wondering how your business can benefit from our new product launch engagement? Request more information from our experts!

Infiniti’s new product launch engagement offered predictive insights on:

• Keeping pace with evolving cPMG (Current Good Manufacturing Practice) regulations in the market
• Understanding how well the new injectable cholesterol drug will compete in the market compared to competitors, in terms of the price and capability
• Want to gain more insights into our services portfolio? Request free brochure.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

Contacts

Infiniti Research

Anirban Choudhury

Marketing Manager

US: +1 844 778 0600

UK: +44 203 893 3400

https://www.infinitiresearch.com/contact-us